Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole.

[1]  C. Lanusse,et al.  Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations. , 2011, Journal of veterinary pharmacology and therapeutics.

[2]  V. Lovera,et al.  Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). , 2011, Veterinary parasitology.

[3]  I. Fairweather.  Liver fluke isolates: a question of provenance. , 2011, Veterinary parasitology.

[4]  I. Fairweather,et al.  Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug , 2010, Parasitology Research.

[5]  C. Lanusse,et al.  Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole , 2010, Parasitology Research.

[6]  C. Lanusse,et al.  Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica , 2008, Parasitology.

[7]  A. Lifschitz,et al.  Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. , 2008, Journal of veterinary pharmacology and therapeutics.

[8]  A. Ivens,et al.  Fasciola hepatica expresses multiple α- and β-tubulin isotypes , 2008, Molecular and biochemical parasitology.

[9]  R. Kaminsky,et al.  Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. , 2007, Veterinary parasitology.

[10]  C. Lanusse,et al.  RESISTANCE-INDUCED CHANGES IN TRICLABENDAZOLE TRANSPORT IN FASCIOLA HEPATICA: IVERMECTIN REVERSAL EFFECT , 2006, The Journal of parasitology.

[11]  I. Fairweather,et al.  Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha , 2006, Parasitology.

[12]  I. Fairweather.  Triclabendazole: new skills to unravel an old(ish) enigma , 2005, Journal of helminthology.

[13]  G. Virkel,et al.  Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes , 2005, Parasitology.

[14]  I. Fairweather,et al.  A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. , 2004, Journal of molecular graphics & modelling.

[15]  I. Fairweather,et al.  Drug resistance in veterinary helminths. , 2004, Trends in parasitology.

[16]  C. Lanusse,et al.  Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy. , 2004, Experimental parasitology.

[17]  I. Fairweather,et al.  The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica , 2004, Parasitology Research.

[18]  C. Lanusse,et al.  Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium , 2004, Parasitology.

[19]  G. Mitchell.  Update on fasciolosis in cattle and sheep , 2002, In Practice.

[20]  J. Cabaret,et al.  Mutation in position 167 of isotype 1 beta-tubulin gene of Trichostrongylid nematodes: role in benzimidazole resistance? , 2002, Molecular and biochemical parasitology.

[21]  I. Fairweather,et al.  Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole , 2002, Parasitology.

[22]  G. Coles,et al.  Activity of oxyclozzanide, nitroxynil, clorsulon and albendazole against adult triclabendazole resistant Fasciola hepatica , 2001, Veterinary Record.

[23]  Robert H. Schmidt,et al.  2000 Report of the AVMA Panel on Euthanasia. , 2001, Journal of the American Veterinary Medical Association.

[24]  C. Gaasenbeek,et al.  Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands. , 2000, Veterinary parasitology.

[25]  I. Fairweather,et al.  Fasciolicides: efficacy, actions, resistance and its management. , 1999, Veterinary journal.

[26]  C. Lanusse,et al.  In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. , 1999, Journal of veterinary pharmacology and therapeutics.

[27]  P. Cooper,et al.  Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[28]  J. A. van Wyk,et al.  Quality control in generic anthelmintics: is it adequate? , 1997, Veterinary parasitology.

[29]  C. Lanusse,et al.  Modified plasma and abomasal disposition of albendazole in nematode-infected sheep. , 1997, Veterinary parasitology.

[30]  Overend Dj,et al.  Resistance of Fasciola hepatica to triclabendazole , 1995 .

[31]  J. Malone,et al.  World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine) , 1995, Veterinary parasitology.

[32]  M. Kwa,et al.  Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in β-tubulin isotype 1 , 1994 .

[33]  R. Prichard,et al.  Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. , 1991, Experimental parasitology.

[34]  R. Prichard,et al.  Beta-tubulin and benzimidazole resistance in the sheep nematode Haemonchus contortus. , 1991, Molecular and biochemical parasitology.

[35]  Q. Mckellar,et al.  The benzimidazole anthelmintic agents--a review. , 1990, Journal of veterinary pharmacology and therapeutics.

[36]  D. Büttner,et al.  The effects of triclabendazole on the lung fluke, Paragonimus uterobilateralis in the experimental host Sigmodon hispidus. , 1988, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[37]  E. Lacey.  The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. , 1988, International journal for parasitology.

[38]  G. Sarasin,et al.  Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole , 1983, Veterinary Record.

[39]  Robert H. Schmidt,et al.  Report of the AVMA panel on euthanasia. , 1978, Journal of the American Veterinary Medical Association.